Come up with a name for your new list and we'll add to it:
Selecta Biosciences raised a round of funding on June 18, 2014. Investors include
National Institutes of Health.
Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic a…